XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes in Shareholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period at Dec. 31, 2020 $ 2,972,656 $ 0 $ 165,367 $ 1,875,626 $ 783,892 $ 147,771
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 86,818       86,818  
Other comprehensive income (loss) (55,862)         (55,862)
Dividends - common stock (23,195)       (23,195)  
Common stock issued 139   9 130    
Common stock repurchased (2,856)   (160) (2,696)    
Share-based compensation expense 1,747     1,747    
Stock activity under incentive compensation plans 0   460 (235) (225)  
Balance at end of period at Mar. 31, 2021 2,979,447 0 165,676 1,874,572 847,290 91,909
Balance at beginning of period at Dec. 31, 2020 2,972,656 0 165,367 1,875,626 783,892 147,771
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 149,604          
Other comprehensive income (loss) (85,509)          
Issuance of common stock   0 0      
Balance at end of period at Jun. 30, 2021 2,991,118 0 165,732 1,876,372 886,752 62,262
Balance at beginning of period at Mar. 31, 2021 2,979,447 0 165,676 1,874,572 847,290 91,909
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 62,786       62,786  
Other comprehensive income (loss) (29,647)         (29,647)
Dividends - common stock (23,202)       (23,202)  
Common stock issued 143   7 136    
Common stock repurchased (449)   (24) (425)    
Share-based compensation expense 1,816     1,816    
Stock activity under incentive compensation plans 224   73 273 (122)  
Balance at end of period at Jun. 30, 2021 2,991,118 0 165,732 1,876,372 886,752 62,262
Balance at beginning of period at Dec. 31, 2021 3,012,018 0 165,838 1,880,545 968,010 (2,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (27,586)       (27,586)  
Other comprehensive income (loss) (335,824)         (335,824)
Issuance of common stock 2,446,312   129,365 2,316,947    
Issuance of preferred stock, net of issuance costs 243,719 230,500   13,219    
Dividends - common stock (40,782)       (40,782)  
Preferred dividends (2,017)       (2,017)  
Common stock issued 165   10 155    
Common stock repurchased (70,078)   (3,890) (66,188)    
Share-based compensation expense 6,284     6,284    
Stock activity under incentive compensation plans (97)   1,636 (1,368) (365)  
Balance at end of period at Mar. 31, 2022 5,232,114 230,500 292,959 4,149,594 897,260 (338,199)
Balance at beginning of period at Dec. 31, 2021 3,012,018 0 165,838 1,880,545 968,010 (2,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 87,399          
Other comprehensive income (loss) (566,758)          
Issuance of common stock   243,870 2,446,312      
Balance at end of period at Jun. 30, 2022 5,078,783 230,500 292,893 4,157,543 966,980 (569,133)
Balance at beginning of period at Mar. 31, 2022 5,232,114 230,500 292,959 4,149,594 897,260 (338,199)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 114,985       114,985  
Other comprehensive income (loss) (230,934)         (230,934)
Dividends - common stock (40,901)       (40,901)  
Preferred dividends (4,033)       (4,033)  
Common stock issued 162   10 152    
Common stock repurchased (322)   (21) (301)    
Share-based compensation expense 7,813     7,813    
Stock activity under incentive compensation plans (101)   (55) 285 (331)  
Balance at end of period at Jun. 30, 2022 $ 5,078,783 $ 230,500 $ 292,893 $ 4,157,543 $ 966,980 $ (569,133)